
The UK biotechnology sector is going from strength to strength, having raised an “unprecedented” £900 million on the London Stock …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

